IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 924-934

  Von Der Thüsen, Jan H ^a   Borensztajn, Keren S ^b   Moimas, Silvia ^c   Van Heiningen, Sandra ^d   Teeling, Peter ^a   Van Berkel, Theo J C ^e   Biessen, Erik A L ^e,f  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; APOLIPOPROTEIN E; COLLAGEN TYPE 3; COLLAGEN TYPE 3A1; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 79951824369     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.007     Document Type: Article

References (50)

1. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868-874
2. Stoll G, Bendszus M: Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006, 37:1923-1932 (Pubitemid 44297753)
3. Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006, 69:625-635 (Pubitemid 43139725)
4. Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 2003, 14:469-475 (Pubitemid 37297301)
5. Clarke M, Bennett M. The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 2006, 26:531-535 (Pubitemid 46143874)
6. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006, 12:1075-1080 (Pubitemid 44353389)
7. von der Thusen JH, van Vlijmen BJ, Hoeben RC, Kockx MM, Havekes LM, van Berkel TJ, Biessen EA. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 2002, 105:2064-2070 (Pubitemid 34465269)
8. Zadelaar AS, von der Thusen JH, Boesten LS, Hoeben RC, Kockx MM, Versnel MA, van Berkel TJ, Havekes LM, Biessen EA, van Vlijmen BJ. Increased vulnerability of advanced atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer. Atherosclerosis 2005, 183:244-250 (Pubitemid 41579274)
9. Bayes-Genis A, Conover CA, Schwartz RS: The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000, 86:125-130 (Pubitemid 30086171)
10. Grant MB, Wargovich TJ, Ellis EA, Tarnuzzer R, Caballero S, Estes K, Rossing M, Spoerri PE, Pepine C: Expression of IGF-I. IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens Regul Pept 1996, 67:137-144
11. Delafontaine P, Song YH, Li Y: Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels Arterioscler Thromb Vasc Biol 2004, 24:435-444
12. Kawachi S, Takeda N, Sasaki A, Kokubo Y, Takami K, Sarui H, Hayashi M, Yamakita N, Yasuda K: Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:617-621 (Pubitemid 40315687)
13. Hietaniemi M, Poykko SM, Ukkola O, Paivansalo M, Antero Kesaniemi Y: IGF-I concentrations are positively associated with carotid artery atherosclerosis in women. Ann Med 2005, 37:373-382 (Pubitemid 41379844)
14. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002, 106:939-944 (Pubitemid 34925327)
15. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P: IGF-1 reduces inflammatory responses, suppresses oxidative stress and decreases atherosclerosis progression in Apoe-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:2684-2690 (Pubitemid 350158923)
16. Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P: Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 2001, 33:1777-1789 (Pubitemid 32977132)
17. Patel VA, Zhang QJ, Siddle K, Soos MA, Goddard M, Weissberg PL, Bennett MR: Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 2001, 88:895-902 (Pubitemid 32441467)
18. Michon IN, Penning LC, Molenaar TJ, van Berkel TJ, Biessen EA, Kuiper J. The effect of TGF-beta receptor binding peptides on smooth muscle cells. Biochem Biophys Res Commun 2002, 293:1279-1286 (Pubitemid 34681080)
19. 't Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J: Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 2003, 93:262-269
20. von der Thusen JH, van Berkel TJ, Biessen EA: Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 2001, 103:1164-1170
21. Arnqvist HJ, Bornfeldt KE, Chen Y, Lindstrom T: The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 1995, 44:58-66
22. Scheidegger KJ, Du J, Delafontaine P: Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor. J Biol Chem 1999, 274:3522-3530 (Pubitemid 29077193)
23. Delafontaine P, Anwar A, Lou H, Ku L: G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 1996, 97:139-145
24. Du J, Brink M, Peng T, Mottironi B, Delafontaine P: Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circ Res 2001, 88:1044-1052 (Pubitemid 34137117)
25. Scheidegger KJ, James RW, Delafontaine P: Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J Biol Chem 2000, 275:26864-26869
26. Higashi Y, Peng T, Du J, Sukhanov S, Li Y, Itabe H, Parthasarathy S, Delafontaine P: A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor. J Lipid Res 2005, 46:1266-1277 (Pubitemid 43109841)
27. Li Y, Higashi Y, Itabe H, Song YH, Du J, Delafontaine P. Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway. Arterioscler Thromb Vasc Biol 2003, 23:2178-2184 (Pubitemid 37532317)
28. Zimmermann EM, Li L, Hou YT, Cannon M, Christman GM, Bitar KN. IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am J Physiol 1997, 273:G875-G882
29. Zeeh JM, Riley NE, Hoffmann P, Reinshagen M, Goebell H, Gerken G: Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats. Eur J Gastroenterol Hepatol 2001, 13:851-858 (Pubitemid 32656600)
30. Xin X, Hou YT, Li L, Schmiedlin-Ren P, Christman GM, Cheng HL, Bitar KN, Zimmermann EM: IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2004, 286:G777-G783
31. Badesch DB, Lee PD, Parks WC, Stenmark KR: Insulin-like growth factor I stimulates elastin synthesis by bovine pulmonary arterial smooth muscle cells. Biochem Biophys Res Commun 1989, 160:382-387 (Pubitemid 19116508)
32. Anwar A, Zahid AA, Scheidegger KJ, Brink M, Delafontaine P: Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin- like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 2002, 105:1220-1225 (Pubitemid 34225824)
33. Jia G, Cheng G, Soundararajan K, Agrawal DK: Insulin-like growth factor-I receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFNgamma. Am J Physiol Heart Circ Physiol 2007, 292:H1051-H1057
34. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47:C13-C18
35. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005, 85:1-31
36. Johnson JL, George SJ, Newby AC, Jackson CL: Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A 2005, 102:15575-15580
37. de Nooijer R, Verkleij CJ, von der Thusen JH, Jukema JW, van der Wall EE, van Berkel TJ, Baker AH, Biessen EA: Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 2006, 26:340-346
38. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW: Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995, 92:1393-1398
39. Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW: Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Eur J Clin Invest 2005, 35:537-545 (Pubitemid 41243296)
40. Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, Nakamura Y, Kawarabayashi T, Iida H, Yoshiyama M, Yoshikawa J: Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006, 97:175-180 (Pubitemid 43139231)
41. Zhang D, Samani AA, Brodt P. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res 2003, 35:802-808 (Pubitemid 38058186)
42. Long L, Navab R, Brodt P: Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res 1998, 58:3243-3247 (Pubitemid 28371059)
43. Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P: Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. J Pathol 2004, 202:50-59 (Pubitemid 38072845)
44. Risinger GM Jr., Hunt TS, Updike DL, Bullen EC, Howard EW: Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem 2006, 281:25915-25925 (Pubitemid 44401797)
45. Randeva HS, Lewandowski KC, Komorowski J, Murray RD, O'Callaghan CJ, Hillhouse EW, Stepien H, Shalet SM: Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals. Circulation 2004, 109:2405-2410
46. Pukac L, Huangpu J, Karnovsky MJ: Platelet-derived growth factor- BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res 1998, 242:548-560 (Pubitemid 28359836)
47. von der Thüsen JH, Kuiper J, Fekkes ML, De Vos P, Van Berkel TJ, Biessen EA: Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 2001, 15:2730-2732
48. de Nooijer R, Verkleij CJ, von der Thüsen JH, Jukema JW, van der Wall EE, van Berkel TJ, Baker AH, Biessen EA: Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 2006, 26:340-346
49. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R: Concept of vulnerable/ unstable plaque. Arterioscler Thromb Vasc Biol 2010, 30:1282-1292
50. Moschos SJ, Mantzoros CS: The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 2002, 63:317-332 (Pubitemid 36151524)